Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ARRY > SEC Filings for ARRY > Form 8-K on 9-Dec-2013All Recent SEC Filings

Show all filings for ARRAY BIOPHARMA INC

Form 8-K for ARRAY BIOPHARMA INC


9-Dec-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On December 9, 2013, Array BioPharma issued two press releases. The press releases announced that Array provided clinical updates on two drug candidates, newly named filanesib (ARRY-520), a KSP inhibitor, and ARRY-614, a dual p38/Tie2 inhibitor, both of which were presented at the 2013 Annual Meeting of the American Society of Hematology (ASH).

Copies of the press releases are attached to this Form 8-K as Exhibit 99.1 and Exhibit 99.2 and are incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.   Description
   99.1       Press Release announcing clinical update on filanesib (ARRY-520) for
              multiple myeloma at the 2013 ASH Meeting
   99.2       Press Release announcing clinical update on ARRY-614 for
              myelodysplastic syndromes at the 2013 ASH Meeting


  Add ARRY to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ARRY - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.